Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 110 (1) , 174-182
- https://doi.org/10.1067/mai.2002.125827
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergyJournal of Allergy and Clinical Immunology, 2002
- Fatal Anaphylaxis Due to Fire Ant StingsAmerican Journal of Forensic Medicine & Pathology, 1998
- Interpreting treatment effects in randomised trialsBMJ, 1998
- Discontinuing venom immunotherapy: Outcome after five yearsJournal of Allergy and Clinical Immunology, 1996
- Measurement of health statusControlled Clinical Trials, 1989
- Development and testing of a new measure of health status for clinical trials in heart failureJournal of General Internal Medicine, 1989
- Venom skin tests in insect-allergic and insect-nonallergic populationsJournal of Allergy and Clinical Immunology, 1985
- Death Caused by Wasp and Bee Stings in Denmark 1960–1980Allergy, 1983
- A Controlled Trial of Immunotherapy in Insect HypersensitivityNew England Journal of Medicine, 1978
- Diagnosis and Treatment of Insect SensitivityJournal of Asthma Research, 1966